Permanent cerebral ischemia induces sustained procaspase 9L increase not controlled by Bcl-2

Brain Research

Volumn 966, Issue 1, 2003, Pages 26-39

  Pfister, Y ^a   Savioz, A ^a   Vallet, P G ^a   Dubois Dauphin, M ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Apoptosis; Bcl 2, caspase; Cytochrome c; Stroke

Indexed keywords

CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; PROCASPASE 9L; PROCASPASE 9S; PROTEIN; PROTEIN BCL 2; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CELL DESTRUCTION; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE OVEREXPRESSION; HEMISPHERE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE;

EID: 0037436424     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04147-1     Document Type: Article

References (54)

1. Alnemri E.S., Fernandes-Alnemri T., Litwack G. Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J. Biol. Chem. 270:1995;4312-4317.
2. Angelastro J.M., Moon N.Y., Liu D.X., Yang A.S., Greene L.A., Franke T.F. Characterization of a novel isoform of caspase-9 that inhibits apoptosis. J. Biol. Chem. 276:2001;12190-12200.
3. Beckmann N. High resolution magnetic resonance angiography non-invasively reveals mouse strain differences in the cerebrovascular anatomy in vivo. Magn. Reson. Med. 44:2000;252-258.
4. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
5. Counis M.F., Torriglia A. DNases and apoptosis. Biochem. Cell. Biol. 78:2000;405-414.
6. de Bilbao F., Giannakopoulos P., Srinivasan A., Dubois-Dauphin M. In vivo study of motoneuron death induced by nerve injury in mice deficient in the caspase 1/interleukin-1 beta-converting enzyme. Neuroscience. 98:2000;573-583.
7. de Bilbao F., Guarin E., Nef P., Vallet P., Giannakopoulos P., Dubois-Dauphin M. Cell death is prevented in thalamic fields but not in injured neocortical areas after permanent focal ischaemia in mice overexpressing the anti-apoptotic protein Bcl-2. Eur. J. Neurosci. 12:2000;921-934.
8. de Moor C.H., Richter J.D. Translational control in vertebrate development. Int. Rev. Cytol. 203:2001;567-608.
9. Droin N., Beauchemin M., Solary E., Bertrand R. Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade. Cancer Res. 60:2000;7039-7047.
10. Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.W., Dixit V.M. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:1996;16720-16724.
11. Dubois-Dauphin M., Frankowski H., Tsujimoto Y., Huarte J., Martinou J.C. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA. 91:1994;3309-3313.
12. Fernandes-Alnemri T., Litwack G., Alnemri E.S. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res. 55:1995;2737-2742.
13. Fernandes-Alnemri T., Takahashi A., Armstrong R., Krebs J., Fritz L., Tomaselli K.J., Wang L., Yu Z., Croce C.M., Salveson G., et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55:1995;6045-6052.
14. Fujita E., Jinbo A., Matuzaki H., Konishi H., Kikkawa U., Momoi T. Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem. Biophys. Res. Commun. 264:1999;550-555.
15. Fujita E., Urase K., Egashira J., Miho Y., Isahara K., Uchiyama Y., Isoai A., Kumagai H., Kuida K., Motoyama N., Momoi T. Detection of caspase-9 activation in the cell death of the Bcl-x-deficient mouse embryo nervous system by cleavage sites-directed antisera. Brain Res. Dev. Brain Res. 122:2000;135-147.
16. Goldstein J.C., Waterhouse N.J., Juin P., Evan G.I., Green D.R. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell. Biol. 2:2000;156-162.
17. Gross A., Jockel J., Wei M.C., Korsmeyer S.J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17:1998;3878-3885.
18. Guegan C., Vila M., Rosoklija G., Hays A.P., Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21:2001;6569-6576.
19. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
20. Hockenbery D.M., Zutter M., Hickey W., Nahm M., Korsmeyer S.J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA. 88:1991;6961-6965.
21. Huang Y., Shin N.H., Sun Y., Wang K.K. Molecular cloning and characterization of a novel caspase-3 variant that attenuates apoptosis induced by proteasome inhibition. Biochem. Biophys. Res. Commun. 283:2001;762-769.
22. Jiang X., Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275:2000;31199-31203.
23. Joza N., Susin S.A., Daugas E., Stanford W.L., Cho S.K., Li C.Y., Sasaki T., Elia A.J., Cheng H.Y., Ravagnan L., Ferri K.F., Zamzami N., Wakeham A., Hakem R., Yoshida H., Kong Y.Y., Mak T.W., Zuniga-Pflucker J.C., Kroemer G., Penninger J.M. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature. 410:2001;549-554.
24. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
25. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-562.
26. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
27. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412:2001;95-99.
28. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
29. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
30. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157.
31. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
32. Mendez R., Richter J.D. Translational control by CPEB: a means to the end. Nat. Rev. Mol. Cell. Biol. 2:2001;521-529.
33. Monaghan P., Robertson D., Amos T.A., Dyer M.J., Mason D.Y., Greaves M.F. Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 40:1992;1819-1825.
34. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:2000;98-103.
35. Ng P.W., Porter A.G., Janicke R.U. Molecular cloning and characterization of two novel pro-apoptotic isoforms of caspase-10. J. Biol. Chem. 274:1999;10301-10308.
36. Nguyen M., Millar D.G., Yong V.W., Korsmeyer S.J., Shore G.C. Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem. 268:1993;25265-25268.
37. Qin H., Srinivasula S.M., Wu G., Fernandes-Alnemri T., Alnemri E.S., Shi Y. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature. 399:1999;549-557.
38. Reed J.C. Mechanisms of apoptosis. Am. J. Pathol. 157:2000;1415-1430.
39. Salvesen G.S., Dixit V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA. 96:1999;10964-10967.
40. Scaffidi C., Medema J.P., Krammer P.H., Peter M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 272:1997;26953-26958.
41. Seol D.W., Billiar T.R. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. 274:1999;2072-2076.
42. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1:1998;949-957.
43. Srinivasula S.M., Ahmad M., Guo Y., Zhan Y., Lazebnik Y., Fernandes-Alnemri T., Alnemri E.S. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res. 59:1999;999-1002.
44. Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., Salvesen G.S. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:1999;8359-8362.
45. Stennicke H.R., Salvesen G.S. Catalytic properties of the caspases. Cell Death Differ. 6:1999;1054-1059.
46. Stennicke H.R., Salvesen G.S. Caspases - controlling intracellular signals by protease zymogen activation. Biochim. Biophys. Acta. 1477:2000;299-306.
47. Steward O., Schuman E.M. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:2001;299-325.
48. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D.R., Aebersold R., Siderovski D.P., Penninger J.M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
49. Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331-1341.
50. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
51. Vukosavic S., Stefanis L., Jackson-Lewis V., Guegan C., Romero N., Chen C., Dubois-Dauphin M., Przedborski S. Delaying caspase activation by bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20:2000;9119-9125.
52. Wu L., Wells D., Tay J., Mendis D., Abbott M.A., Barnitt A., Quinlan E., Heynen A., Fallon J.R., Richter J.D. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation of alpha-CaMKII mRNA at synapses. Neuron. 21:1998;1129-1139.
53. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275:1997;1129-1132.
54. Zou H., Li Y., Liu X., Wang X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:1999;11549-11556.